How is the Clinical Nutrition For Cancer Care Market Poised for Growth: Trends and Opportunities Through 2034
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
What is the Predicted Annual Growth Rate of the Clinical Nutrition For Cancer Care Market Over the Coming Decade?
The market for clinical nutrition specific to cancer treatment has experienced robust growth over the past few years. Its size is set to increase from $4.92 billion in 2024 to $5.22 billion in 2025, with a compound annual growth rate (CAGR) of 5.9%. The significant growth witnessed during the historic period is due to factors such as increasing awareness about the importance of nutrition, the advent of precision nutrition strategies, modifications in healthcare policies and reimbursement schemes, surgical procedures for treating cancer, and a rising interest in functional foods, nutraceuticals, and dietary supplements.
The market for clinical nutrition in cancer care is set to experience substantial expansion in the coming years, with predicted growth to $6.48 billion by 2029, reflecting a compound annual growth rate (CAGR) of 5.6%. Factors driving this predicted upturn include a shift in preference to personalized and precision nutrition tactics, a surge in the demand for clinical nutrition support for patients, a rising recognition of the relevance of nutrition to the results of cancer treatment, advancements in cancer medicine, and the incorporation of structured clinical nutrition regimes within oncology. Key trends for the forecast period encompass advances in research on nutritional biomarkers, innovation in nutritional products and their delivery systems, increased teamwork amongst oncologists, continuous advancements in the field of nutritional science, and sustained research and development efforts.
What Factors Are Propelling the Growth of the Clinical Nutrition For Cancer Care Market from 2025 to 2034?
The anticipated upsurge in cancer cases is projected to drive the expansion of the clinical nutrition for cancer care market. Cancer, characterized by unregulated cellular proliferation and potentially metastasizing to other body parts, becomes a higher risk as life expectancy rises, making an aging population more vulnerable to the disease. Clinical nutrition for cancer care, which offers unique nutritional sustenance and diet management for cancer patients, aims to enhance treatment efficacy. As an example, the World Health Organization, a US-based intergovernmental agency, predicted in February 2024 that the number of cancer cases would reach around 35 million in 2050, marking a 77% rise from the projected 20 million cases in 2022. Thus, the climbing cancer incidence prompts the progress of the clinical nutrition for cancer care market.
Request Your Free Clinical Nutrition For Cancer Care Market Report Sample Now!
https://www.thebusinessresearchcompany.com/sample.aspx?id=16017&type=smp
What Are the Major Players Making an Impact in the Clinical Nutrition For Cancer Care Market’s Growth?
Major companies operating in the clinical nutrition for cancer care market are:
• Pfizer Inc.
• Bayer AG
• Abbott Nutrition
• GlaxoSmithKline plc
• Reckitt Benckiser Group plc
Which Upcoming Trends Are Set to Influence the Clinical Nutrition For Cancer Care Market’s Path Forward?
Leading firms in the clinical nutrition for cancer care market are innovating with products like oral nutritional supplements, with a view to achieve a competitive advantage. These supplements are specially engineered food products, meant to cater to the specific nutritional needs of people with certain medical conditions. In July 2022, for instance, Nestle, a Switzerland-based food and beverage processing giant, introduced the very first Foods Oral Impact Su Yi Su to China. The product, which includes arginine and fish omega-3 along with other fundamental nutritional elements for specific medicinal uses (FSMP), is intended for patients dealing with tumor-related issues, earning its approval from the Chinese regulator after a five-year process. The Oral Impact Su Yi Su is a distinctively approved food for FSMP nutritional supplement. Its design is specifically aimed to serve individuals with medical conditions or dietary requirements, tailoring to their unique nutritional needs while undergoing cancer treatments.
Pre-order Your Report for Quick and Easy Delivery!
What Are the Core Segments of the Clinical Nutrition For Cancer Care Market, and How Do They Contribute to Growth?
The clinical nutrition for cancer care market covered in this report is segmented –
1) By Type: Oral Nutrition, Parenteral Nutrition, Enteral Feeding Formulas
2) By Cancer Type: Head And Neck Cancer, Stomach And Gastrointestinal Cancers, Blood Cancer, Breast Cancer, Lung Cancer, Other Cancer Types
3) By Age Group: Adult, Pediatric
4) By Sales Channel: Online, Retail, Institutional Sales
Subsegments:
1) By Oral Nutrition: Protein-Rich Supplements, Carbohydrate-Rich Supplements, Fat-Rich Supplements, Vitamins And Mineral Supplements, Caloric Supplements, Fiber-Enriched Supplements
2) By Parenteral Nutrition: Amino Acids, Carbohydrates, Lipids, Electrolytes And Micronutrients, Intravenous Fat Emulsions, Trace Elements And Vitamins
3) By Enteral Feeding Formulas: Standard Enteral Feeding Formulas, High-Protein Enteral Formulas, High-Calorie Enteral Formulas, Diabetic Enteral Formulas, Elemental Enteral Formulas, Specialized Enteral Formulas
What Regions Are Steering Growth in the Clinical Nutrition For Cancer Care Sector?
North America was the largest region in the clinical nutrition for cancer care market in 2023. The regions covered in the clinical nutrition for cancer care market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Are the Core Features That Define the Clinical Nutrition For Cancer Care Market?
Clinical nutrition for cancer care refers to the specialized dietary support and interventions tailored to meet the nutritional needs of cancer patients throughout their treatment journey. It involves the provision of personalized nutrition plans aimed at managing symptoms, optimizing treatment outcomes, and improving the overall quality of life for individuals undergoing cancer therapy.
Browse Through More Similar Reports By The Business Research Company:
Nutritional Feed Additives Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/nutritional-feed-additives-global-market-report
Oncology Nutrition Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/oncology-nutrition-global-market-report
Sports Nutrition Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/sports-nutrition-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
